Almış Behice Han, Eğilmez Oğuzhan Bekir
Department of Psychiatry, Adıyaman University School of Medicine, Adıyaman, Turkey.
Psychiatry Clin Psychopharmacol. 2021 Sep 1;31(3):339-343. doi: 10.5152/pcp.2021.21695. eCollection 2021 Sep.
Measurement of platelet parameters, especially mean platelet volume (MPV), in mental disorders has been gaining importance. MPV is an indicator of platelet activity, and increased MPV is considered a risk factor for cardiovascular disease. Cardiovascular diseases and associated mortality are more common in patients with schizophrenia (SZ) and bipolar disorder (BD) than in the general population. We aimed to evaluate platelet parameters, including MPV, platelet count (PLT), platelet distribution volume (PDW), and plateletcrit (PCT) level, in first-episode patients with SZ and BD before disease progression and the effect of antipsychotic drugs caused changes in their lives.
In this retrospective cohort study, we compared the platelet parameters in 72 patients with SZ at the time of their first psychotic episode and 63 patients with BD at the time of their first manic episode with 64 healthy controls.
SZ group had significantly lower MPV and PCT values than the control group ( = .003 and = .03, respectively). BD group had significantly lower MPV and PCT values than the control group ( = .001 and = .02, respectively).
This is the first study to compare the platelet parameters between first-episode patients with SZ and BD and healthy controls. Although a few studies have reported an increase or decrease in platelet parameters in SZ and BD, our results are valuable in terms of evaluating platelet parameters in first-episode patients who have not started drugs.
在精神障碍中,血小板参数的测量,尤其是平均血小板体积(MPV),变得越来越重要。MPV是血小板活性的指标,MPV升高被认为是心血管疾病的危险因素。精神分裂症(SZ)和双相情感障碍(BD)患者的心血管疾病及相关死亡率比普通人群更为常见。我们旨在评估首发SZ和BD患者在疾病进展前的血小板参数,包括MPV、血小板计数(PLT)、血小板分布宽度(PDW)和血小板压积(PCT)水平,以及抗精神病药物对其生活造成的影响。
在这项回顾性队列研究中,我们将72例首次精神病发作时的SZ患者和63例首次躁狂发作时的BD患者的血小板参数与64名健康对照者进行了比较。
SZ组的MPV和PCT值显著低于对照组(分别为=0.003和=0.03)。BD组的MPV和PCT值显著低于对照组(分别为=0.001和=0.02)。
这是第一项比较首发SZ和BD患者与健康对照者血小板参数的研究。尽管有一些研究报告了SZ和BD患者血小板参数的升高或降低,但我们的结果对于评估未开始用药的首发患者的血小板参数具有重要价值。